ClinConnect ClinConnect Logo
Search / Trial NCT05526352

@neurIST : Intregrated Biomedical Informatics for the Management of Cerebral Aneurysms

Launched by UNIVERSITY HOSPITAL, GENEVA · Aug 31, 2022

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

ClinConnect Summary

The @neurIST clinical trial is focused on understanding and managing a condition known as intracranial aneurysms, which are bulges in blood vessels in the brain that can pose serious health risks. The main goal is to create a comprehensive database that collects important information about these aneurysms. Researchers will look at various factors that might increase the risk of developing these aneurysms or the likelihood of them bursting, such as genetics and environmental influences. They will also evaluate different treatment options, like monitoring the aneurysm, surgery, or other medical procedures, to see which approaches work best for patients.

To participate in this trial, individuals must have a confirmed intracranial aneurysm and be able to give consent, or have someone legally authorized to provide consent for them. The trial is open to all patients aged 65 to 74, and participants can expect to have their medical information used to help create personalized treatment plans based on the latest research. Overall, this study aims to improve care, lower costs, and advance knowledge in the treatment of cerebral aneurysms.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • able to provide consent or, in the event that a patient is incapable of providing consent, that a person is legally authorized to do so on behalf of the patient according to legal and ethical requirements of the country where the clinical centre is located.
  • Patients:
  • must have an angiographically proven intracranial aneurysm (MRA\< CTA\< DSA accepted).The determination of SAH requires the presence of a subarachnoid haemorrhage be verified on CT or by lumbar puncture.
  • MRA: Magnetic Resonance Angiography CTA: Computed Tomography Angiography DSA: Digital Subtracted Angiography
  • Exclusion Criteria:
  • failure of a candidate to contribute clinical data,
  • refusal to provide informed consent.

About University Hospital, Geneva

The University Hospital of Geneva is a leading academic medical center committed to advancing healthcare through innovative research and clinical excellence. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge medical research with high-quality patient care, fostering a collaborative environment that encourages the translation of scientific discoveries into practical treatments. As a prominent sponsor of clinical trials, the University Hospital of Geneva is dedicated to exploring new therapies and improving patient outcomes, while adhering to the highest ethical standards and regulatory compliance. Its robust infrastructure and expert clinical teams ensure the efficient execution of trials across various medical specialties, contributing significantly to the advancement of global health initiatives.

Locations

Helsinki, , Finland

Cincinnati, Ohio, United States

San Francisco, California, United States

Utrecht, , Netherlands

Barcelona, , Spain

Rotterdam, , Netherlands

Kuopio, , Finland

Sheffield, , United Kingdom

London, , United Kingdom

Rotterdam, Zuid Holland, Netherlands

Pécs, , Hungary

London, , United Kingdom

Cracovia, , Poland

Geneva, , Switzerland

Zürich, , Switzerland

Virginia Beach, Virginia, United States

Montréal, , Canada

Nantes, , France

Barcelona, , Spain

Barcelona, , Spain

Oxford, , United Kingdom

Munich, , Germany

Saint Gallen, , Switzerland

Patients applied

0 patients applied

Trial Officials

Philippe Bijlenga, PD MD PhD

Principal Investigator

Geneva University

Sandrine Morel, PD PhD

Study Chair

Hôpitaux Universitaire de Genève

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials